# Helmut M. Schühsler

> Helmut M. Schühsler is a Series B investor at TVM Capital Healthcare backing Health Care. See 4 investments, check sizes, portfolio. Updated Aug 2026.

- Type: Angel Investor
- Fund: [TVM Capital Healthcare](https://shizune.co/investors/profile/tvm-capital-healthcare)
- Total investments: 4
- Last investment: Jul 2025
- Lead investor: 75%
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/in/helmut-schuehsler-740b5817

Helmut M. Schühsler is a Series B investor at TVM Capital Healthcare focused on Health Care and Biotechnology. Helmut M. Schühsler - Chairman and CEO @ TVM Capital Healthcare

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Health Care | 4 | 100% |
| Biotechnology | 3 | 75% |
| Medical | 1 | 25% |
| Genetics | 1 | 25% |
| Oncology | 1 | 25% |

8 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Series B | 2 | 50% |
| Funding Round | 1 | 25% |
| Private Equity | 1 | 25% |

### Country

| Country | Investments | Share |
| --- | --- | --- |
| United States | 3 | 75% |
| Saudi Arabia | 1 | 25% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Baraya Extended Care | Baraya is a company specializing in rehabilitation treatment, committed to providing high-quality rehabilitation treatment services to patients. | $124M | Series B | Jul 15, 2025 |  |
| Human Longevity | Human Longevity (HLI) is the genomic-based, health intelligence company empowering proactive healthcare and enabling a life better lived. HLI combines the largest database of genomic and phenotypic data with machine learning to drive discoveries and revolutionize the practice of medicine. Its business areas include the HLI Health Nucleus, a genomicpowered clinical research center that uses whole-genome sequence analysis, advanced clinical imaging, and innovative machine learning, along with curated personal health information to deliver the most complete picture of individual health; HLIQ Whole Genome and HLIQ Oncology. It was founded in 2013 and is headquartered in San Diego, California. | $39.8M | Series B | Aug 21, 2024 |  |
| Boston Oncology | At Boston Oncology, we support the healthcare of citizens in emerging markets around the world through regional development and production of licensed biopharmaceutical products. | $35M | Private Equity | Jun 26, 2024 |  |
| SelectX Pharmaceuticals Inc. | SelectX Pharmaceuticals Inc. is a biopharmaceutical company focused on the discovery and development of aminoglycoside therapeutics for unmet medical needs. It has built an advanced aminoglycoside drug and other drugs. The company’s advanced program, development candidate SXP2523, is a next generation aminoglycoside antibiotic for drug resistantgram-negative hospital-acquired infections.SelectX Pharmaceuticals Inc. is currently developing a next generation inhaled aminoglycoside antibiotic for drug resistant gram-negative infections in patients with Cystic Fibrosis and other respiratory diseases. The company is based in Boston, Massachusetts. |  |  | Jan 01, 2002 |  |

4 of 4 investments shown.

## Co-investors
- [ANB Capital](https://shizune.co/investors/profile/anb-capital-df83) — VC Fund, 1 deal together
- [Emerging Technology Partners](https://shizune.co/investors/profile/emerging-technology-partners) — VC Fund, 1 deal together
- [Olayan Financing Company](https://shizune.co/investors/profile/olayan-financing-company) — VC Fund, 1 deal together
- [Panacea Venture](https://shizune.co/investors/profile/panacea-venture-bb23) — VC Fund, 1 deal together
- [Saudi Venture Capital Company](https://shizune.co/investors/profile/saudi-venture-capital-company) — VC Fund, 1 deal together
- [SEDCO Holding](https://shizune.co/investors/profile/sedco-holding) — VC Fund, 1 deal together

## About TVM Capital Healthcare

VC Fund · Dubai, United Arab Emirates

TVM Capital Healthcare is a highly focused private equity and growth capital firm.

5 contacts available at TVM Capital Healthcare.

| Name | Title | Profile |
| --- | --- | --- |
| Farid Fezou | Managing Partner | https://shizune.co/investors/profile/farid-fezou |
| Farid Fezoua | Managing Partner | https://shizune.co/investors/profile/farid-fezoua-433e |
| Helmut M. Schühsler | Chairman and CEO | https://shizune.co/investors/profile/helmut-m-schhsler |
| Hoda Abou-Jamra | Founding Partner | https://shizune.co/investors/profile/hoda-abou-jamra |
| Orhan Osmansoy | Operating Partner | https://shizune.co/investors/profile/orhan-osmansoy |

## Similar investors

### Similar stage
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [General Catalyst](https://shizune.co/investors/profile/general-catalyst-partners) — VC Fund
- [FJ Labs](https://shizune.co/investors/profile/fj-labs) — VC Fund

## FAQ

### What does Helmut M. Schühsler invest in?

Helmut M. Schühsler invests primarily in Health Care, Biotechnology and Medical startups, most often at Series B and Funding Round stage. Most of the 4 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### When did Helmut M. Schühsler last invest?

The most recent investment recorded for Helmut M. Schühsler closed in Jul 2025. Shizune tracks 4 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co